Abbott Laboratories operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories with three other
companies in this sector in the United States:
Eli Lilly and Company
sales of $21.22 billion
of which 38%
Teva Pharmaceutical Industries Limited
of which 55%
was Generic Madicines), and
Bristol-Myers Squibb Company
of which 100%
During the year ended December of 2016, sales at
Abbott Laboratories were $20.85 billion.
increase of 2.2%
versus 2015, when the company's sales were $20.41 billion.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
5.0% in 2016, from
$2.27 billion to $2.39 billion.
Abbott Laboratories also saw significant increases in sales in
Diagnostics Products (up 3.6% to $4.81 billion)
Established Pharmaceutical Products (up 3.7% to $3.86 billion)
Vascular Products (up 3.7% to $2.90 billion)
Not all segments of Abbott Laboratories experienced an increase in sales in 2016:
sales of Nutritionals fell 1.1% to $6.90 billion.